Group 1 - The company's revenue for the first half of 2025 is 399 million yuan, representing a year-on-year increase of 3.68% [1] - The net profit for the same period is 95.5061 million yuan, showing a year-on-year growth of 7.35% [1] - The company plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves [1]

[Section I Important Notice, Table of Contents, and Definitions](index=2&type=section&id=Section%20I%20Important%20Notice%2C%20Table%20of%20Contents%2C%20and%20Definitions) This section presents crucial disclaimers, a comprehensive table of contents, and definitions of key terms for report clarity and legal compliance [Important Notice](index=2&type=section&id=Important%20Notice) The Board, Supervisory Board, and senior management guarantee the report's truthfulness and completeness, with no plans for cash dividends or bonus shares - The company's Board of Directors, Supervisory Board, and senior management guarantee the truthfulness, accuracy, and completeness of the report content and assume legal responsibility[4](index=4&type=chunk) - The company's head, chief accountant, and head of accounting department declare the financial report to be true, accurate, and complete[4](index=4&type=chunk) - The company plans not to distribute cash dividends, bonus shares, or convert capital reserves into share capital[5](index=5&type=chunk) [Table of Contents](index=3&type=section&id=Table%20of%20Contents) The report's clear table of contents outlines eight main chapters, providing comprehensive navigation for investors - The report comprises eight main chapters, clearly structured for investor review[7](index=7&type=chunk) [Catalogue of Reference Documents](index=4&type=section&id=Catalogue%20of%20Reference%20Documents) Reference documents, including the signed semi-annual report and financial statements, are available at the company's securities department - Reference documents include the semi-annual report text signed by the legal representative, financial statements, original drafts of documents publicly disclosed on the CSRC designated website, and other materials[9](index=9&type=chunk) - All reference documents are kept at the company's securities department[10](index=10&type=chunk) [Definitions](index=5&type=section&id=Definitions) This section defines common terms, including company names, subsidiaries, and financial units, to ensure accurate report comprehension - The definitions section clarifies the meanings of key terms such as the company, subsidiaries, controlling shareholders, and relevant laws and regulations[11](index=11&type=chunk) [Section II Company Profile and Key Financial Indicators](index=6&type=section&id=Section%20II%20Company%20Profile%20and%20Key%20Financial%20Indicators) This section provides an overview of the company's basic information, contact details, and a summary of its key financial performance and indicators for the reporting period [I. Company Profile](index=6&type=section&id=I.%20Company%20Profile) Mingyue Lens Co., Ltd., stock code 301101, is listed on the Shenzhen Stock Exchange with Xie Gongwan as its legal representative Company Basic Information | Indicator | Content | | :--- | :--- | | Stock Abbreviation | Mingyue Lens | | Stock Code | 301101 | | Listing Exchange | Shenzhen Stock Exchange | | Legal Representative | Xie Gongwan | [II. Contact Persons and Information](index=6&type=section&id=II.%20Contact%20Persons%20and%20Information) The company's Board Secretary and Securities Affairs Representative are located in Shanghai, sharing contact details and email Contact Information | Position | Name | Contact Address | Phone | Fax | Email | | :--- | :--- | :--- | :--- | :--- | :--- | | Board Secretary | Zeng Zhe | Pinzun International Center, No. 567 Langao Road, Putuo District, Shanghai | 021-52660665 | 021-52971882 | stock@mingyue.com | | Securities Affairs Representative | Li Heran | Pinzun International Center, No. 567 Langao Road, Putuo District, Shanghai | 021-52660665 | 021-52971882 | stock@mingyue.com | [III. Other Information](index=6&type=section&id=III.%20Other%20Information) Company contact details and registration remained unchanged, but approved amendments to business scope and articles of association are pending registration - The company's registered address, office address, website, email, and other contact information remained unchanged during the reporting period[15](index=15&type=chunk) - Information disclosure and document storage locations remained unchanged during the reporting period[16](index=16&type=chunk) - The company's registration status remained unchanged during the reporting period[17](index=17&type=chunk) - The company has approved proposals to change its business scope and revise its articles of association, but as of June 30, 2025, the industrial and commercial registration has not yet been completed[18](index=18&type=chunk) [IV. Key Accounting Data and Financial Indicators](index=7&type=section&id=IV.%20Key%20Accounting%20Data%20and%20Financial%20Indicators) Operating revenue grew by 3.68%, net profit by 7.35%, and total assets by 2.98%, while operating cash flow decreased by 9.96% Key Accounting Data and Financial Indicators (Year-on-Year Change) | Indicator | Current Reporting Period (RMB) | Prior Year Same Period (RMB) | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Operating Revenue | 399,171,797.71 | 385,020,343.87 | 3.68% | | Net Profit Attributable to Shareholders of Listed Company | 95,506,055.46 | 88,966,730.67 | 7.35% | | Net Profit Attributable to Shareholders of Listed Company After Deducting Non-Recurring Gains and Losses | 82,723,521.52 | 75,497,991.76 | 9.57% | | Net Cash Flow from Operating Activities | 63,946,345.30 | 71,021,733.53 | -9.96% | | Basic Earnings Per Share (RMB/share) | 0.4758 | 0.4415 | 7.77% | | Diluted Earnings Per Share (RMB/share) | 0.4758 | 0.4415 | 7.77% | | Weighted Average Return on Net Assets | 5.62% | 5.59% | 0.03% | | Total Assets (Period-end) | 1,916,607,892.03 | 1,861,102,531.56 | 2.98% | | Net Assets Attributable to Shareholders of Listed Company (Period-end) | 1,664,665,182.47 | 1,669,525,834.67 | -0.29% | [V. Differences in Accounting Data Under Domestic and Overseas Accounting Standards](index=7&type=section&id=V.%20Differences%20in%20Accounting%20Data%20Under%20Domestic%20and%20Overseas%20Accounting%20Standards) The company reported no differences in net profit or net assets under domestic versus international accounting standards during the period - The company reported no differences in net profit and net assets under domestic and overseas accounting standards during the reporting period[20](index=20&type=chunk)[21](index=21&type=chunk) [VI. Non-Recurring Gains and Losses Items and Amounts](index=8&type=section&id=VI.%20Non-Recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) Non-recurring gains and losses totaled **RMB 12,782,533.94**, mainly from financial asset fair value changes and government subsidies Non-Recurring Gains and Losses Items and Amounts | Item | Amount (RMB) | | :--- | :--- | | Gains and losses from disposal of non-current assets | -27,203.47 | | Government subsidies recognized in current profit or loss | 2,751,062.25 | | Gains and losses from changes in fair value of financial assets and financial liabilities, and investment income from disposal of financial assets and financial liabilities, excluding effective hedge accounting related to the company's normal business operations | 12,537,920.48 | | Reversal of impairment provisions for receivables subject to separate impairment testing | 112,996.48 | | Other non-operating income and expenses apart from the above | 32,618.55 | | Less: Income tax impact | 2,486,948.38 | | Minority interest impact (after tax) | 137,911.97 | | Total | 12,782,533.94 | - The company has no other profit or loss items that meet the definition of non-recurring gains and losses, nor does it classify non-recurring items as recurring gains and losses[23](index=23&type=chunk)[24](index=24&type=chunk) [Section III Management Discussion and Analysis](index=9&type=section&id=Section%20III%20Management%20Discussion%20and%20Analysis) This section provides a comprehensive analysis of the company's business operations, core competencies, financial performance, investment activities, and risk factors during the reporting period [I. Main Business Activities During the Reporting Period](index=9&type=section&id=I.%20Main%20Business%20Activities%20During%20the%20Reporting%20Period) Mingyue Lens, a leading domestic optical lens enterprise, continued to deepen brand building and R&D innovation, establishing a complete industry chain and one-stop service system, while expanding into smart glasses and medical channels [(I) Overview of Company Business](index=9&type=section&id=%28I%29%20Overview%20of%20Company%20Business) Mingyue Lens, a leading optical resin lens company, maintained its market leadership through a complete industry chain, continuous R&D, and strategic collaborations in smart wearables and medical channels - **Mingyue Lens** has been the national sales leader for nine consecutive years, firmly establishing its industry-leading position and is the only A-share listed company primarily engaged in optical resin lenses[26](index=26&type=chunk) - The company has built a complete industry chain covering lenses, lens raw materials, finished glasses, and frames, offering a one-stop service system, and has achieved self-sufficiency and open supply of high-quality raw materials such as **1.71**, **KR resin**, **KR ultra-tough**, and **PMC ultra-bright**[26](index=26&type=chunk) - In the first half of 2025, the company launched a new high-refractive index product matrix, including the **PMC Ultra-Bright series** with a new **1.67 refractive index**, **Ultra-Tough series** with **1.67/1.71/1.74 high-index specifications**, new-generation **Smart Photochromic 2.0**, full-refractive index shallow-base anti-blue light series, and new **'Digital Anti-Fatigue'** and **'Vis-Progressive'** series[29](index=29&type=chunk) - The company collaborated with Academician Zhuang Songlin's team to launch **'Easy Control'** and **'Easy Control Pro'** myopia management lenses, with **Easy Control Pro 2.0** showing a **73.82% effective rate** in equivalent spherical power after 12 months of wear, and clinical trial results published in the top international ophthalmology journal *Ophthalmology*[30](index=30&type=chunk)[31](index=31&type=chunk) - The company established an official exclusive optical partnership with **Xiaomi AI Glasses**, providing full-channel dispensing services, and reached an exclusive high-end lens cooperation agreement with **Leica Germany** in 2024[45](index=45&type=chunk)[47](index=47&type=chunk) - The company signed a comprehensive strategic cooperation agreement with **Aier Eye Hospital Group Co., Ltd.**, aiming to integrate their strengths, initiate multi-dimensional and deep-level cooperation, and focus on developing medical channels[49](index=49&type=chunk) [(II) Basic Product Information](index=14&type=section&id=%28II%29%20Basic%20Product%20Information) The company offers a diverse range of daily and functional lenses, including high-refractive index options and advanced myopia management solutions like the "Easy Control Pro 2.0" series, which significantly slows myopia progression - The company's products are categorized into daily general-purpose lenses and functional lenses, with general-purpose lenses covering all common refractive indices of **1.56, 1.60, 1.67, 1.71, and 1.74**, and the **1.71 high-refractive index lens** boasting an Abbe number of up to **37**[55](index=55&type=chunk) - Functional lenses include myopia management (**Easy Control series**), **PMC Ultra-Bright**, **KR Ultra-Tough**, **Dual Anti-Blue Light**, **Smart Photochromic**, **Progressive Multifocal**, and **Polarized** lenses, with **PMC Ultra-Bright lenses** achieving a light transmittance of up to **98.6%**[56](index=56&type=chunk) - The **Easy Control Pro 2.0 series** optimized optical design and imaging quality, increasing the number of micro-lenses from **1,295 to 1,329**, achieving a **73.82% effective rate** in slowing myopia progression[60](index=60&type=chunk) - Easy Control Pro lenses cover refractive indices of **1.56, 1.60, 1.67, and 1.71**, offering advantages such as excellent optical parameters, high cost-effectiveness, light weight, and thin edges[61](index=61&type=chunk) [(III) Sales Model](index=16&type=section&id=%28III%29%20Sales%20Model) The company primarily uses a direct sales model, supplemented by distribution, serving tens of thousands of optical chain stores and ophthalmic medical institutions nationwide, with direct sales accounting for 59.43% of revenue - The company's sales model is primarily direct sales, supplemented by distribution, serving tens of thousands of optical chain stores and ophthalmic medical institutions nationwide[62](index=62&type=chunk) H1 2025 Sales Channel Revenue Share | Channel | Revenue (RMB 10,000) | Share of Operating Revenue | | :--- | :--- | :--- | | Direct Sales Channel | 23,720.88 | 59.43% | | Distribution Channel | 13,270.10 | 33.24% | - In H1 2025, lens business grew by **5.4%** year-on-year, with **PMC Ultra-Bright series** product revenue increasing by **31.77%**[63](index=63&type=chunk) - Sales of the **'Easy Control' series** products were **RMB 81.67 million**, a year-on-year increase of **7.32%**; excluding the impact of product upgrade recalls, sales were **RMB 90.12 million**, an increase of **18.4%**[63](index=63&type=chunk) - Sales of **1.74 series products** rapidly increased, growing by **258%** compared to the same period last year[63](index=63&type=chunk) [II. Analysis of Core Competencies](index=17&type=section&id=II.%20Analysis%20of%20Core%20Competencies) Mingyue Lens's core competencies stem from its strong brand influence, continuous technological innovation, diverse product portfolio, extensive marketing channels, and high-caliber talent team [(I) Brand Advantage](index=17&type=section&id=%28I%29%20Brand%20Advantage) Mingyue Lens has solidified its position as "China's No.1 Lens Brand" with nine consecutive years of leading national sales, enhanced by celebrity endorsements, national collaborations, and robust social media engagement - **Mingyue Lens** has firmly established itself as **'China's No.1 Lens Brand'**, certified by Sullivan for leading national sales for nine consecutive years[64](index=64&type=chunk) - In April 2025, the company officially invited Olympic champion **Guo Jingjing** to be its brand ambassador, significantly elevating brand recognition and public acceptance[64](index=64&type=chunk) - The company has participated in multiple national events, such as sponsoring the Chinese Mountaineering Team, providing visual assurance for Shenzhou XII, collaborating with the Mount Everest scientific expedition team, and serving as the designated lens brand for the CIIE for four consecutive sessions[64](index=64&type=chunk) - The company partnered with **Universal Pictures' 'Minions' IP** to host a series of activities promoting myopia prevention knowledge, and collaborated with renowned talk show host **Yu Xiangyu** and actress **Hu Ke** to enhance brand visibility through diverse content and offline engagement[65](index=65&type=chunk)[66](index=66&type=chunk) [(II) Technological Advantage](index=17&type=section&id=%28II%29%20Technological%20Advantage) Mingyue Lens possesses deep expertise in lens raw materials, optical design, and manufacturing, with independent R&D capabilities, a Academician Workstation for tailored product development, and 162 patents - **Mingyue Lens** has deep expertise in lens raw materials, optical design, coating technology, and production processes, achieving independent R&D of optical software and key raw materials[67](index=67&type=chunk)[68](index=68&type=chunk) - The company collaborates with globally renowned optical expert Academician Zhuang Songlin's team, establishing an industry-demonstration-level **Academician Workstation** and **Eyewear Engineering Technology Center**, focusing on developing products better suited to the ocular characteristics of Chinese people[68](index=68&type=chunk) - The company has established strategic partnerships with institutions such as **Nanjing Tech University**, **University of Shanghai for Science and Technology**, **Changchun Institute of Optics, Fine Mechanics and Physics (CAS)**, and **China Eye Valley** to drive technological innovation[83](index=83&type=chunk)[84](index=84&type=chunk) - As of June 30, 2025, the company holds **162 patents**, including **40 invention patents**[69](index=69&type=chunk) [(III) Product Advantage](index=18&type=section&id=%28III%29%20Product%20Advantage) Mingyue Lens offers a diverse product portfolio, including advanced functional lenses and high-refractive index series, with 36 SKUs in its "Easy Control" myopia management series, and is a key optical supplier for smart wearables like Xiaomi AI Glasses and Leica - The company independently researches and designs lens optical and coating structures, offering diverse products such as **Dual Anti-Blue Light**, **PMC Ultra-Bright**, and **1.67/1.71/1.74 high-refractive index series**[70](index=70&type=chunk) - The company has fully entered the adolescent myopia management lens market, with **36 SKUs** currently available in the **'Easy Control' series**, leading in product line richness[71](index=71&type=chunk)[72](index=72&type=chunk) - **Mingyue Lens** became the official exclusive optical lens supplier for **Xiaomi AI Glasses**, providing a full range of lenses including **1.71 high-refractive index**, **smart photochromic**, **anti-fatigue**, and **progressive** lenses, and collaborated with **Leica** to solidify its strategic position in the smart wearable optical supply chain[74](index=74&type=chunk)[75](index=75&type=chunk) [(IV) Marketing Channel Advantage](index=19&type=section&id=%28IV%29%20Marketing%20Channel%20Advantage) The company leverages an extensive offline marketing network of tens of thousands of stores, supported by customer empowerment activities and a strong presence across new media platforms, enhanced by celebrity endorsements for integrated online-offline marketing - The company's marketing network covers tens of thousands of offline retail stores nationwide, empowering customers through national new product launches, customer salons, and factory open days[76](index=76&type=chunk)[78](index=78&type=chunk)[79](index=79&type=chunk)[80](index=80&type=chunk)[81](index=81&type=chunk) - The company actively develops new media channels, conducting professional science popularization and brand promotion on platforms such as **Douyin, Zhihu, Xiaohongshu, and Bilibili**, with its official Douyin platform accumulating **1.122 million followers**[82](index=82&type=chunk) - The official endorsement by **Guo Jingjing** brought a significant leap in brand visibility and multi-dimensional exposure for **Mingyue Lens**, enhancing brand reputation and attention to myopia management lenses[82](index=82&type=chunk) [(V) Talent and Team Advantage](index=20&type=section&id=%28V%29%20Talent%20and%20Team%20Advantage) Mingyue Lens boasts a multidisciplinary R&D team, collaborating with top research institutions, and an experienced management team with over 20 years of industry expertise, ensuring stable company development - The company's core technical team comprises elite talents from various fields, including optics, materials science, optometry, manufacturing equipment, processing software design, and mathematical modeling[83](index=83&type=chunk) - The company has established long-term strategic partnerships with institutions such as **Nanjing Tech University**, **University of Shanghai for Science and Technology**, **Changchun Institute of Optics, Fine Mechanics and Physics (CAS)**, and **China Eye Valley**, jointly committed to the development of new technologies and materials, and optimization of optical performance design[83](index=83&type=chunk)[84](index=84&type=chunk) - The company's management team members have grown with the company for many years, possessing over **20 years of management experience** in the eyewear industry, focusing on the R&D, design, production, and sales of optometry products[84](index=84&type=chunk) [III. Analysis of Main Business](index=21&type=section&id=III.%20Analysis%20of%20Main%20Business) This reporting period, operating revenue increased by 3.68%, but net cash flow from operating activities decreased by 9.96%, with R&D investment significantly up by 35.45% and financial expenses by 181.57% [Overview](index=21&type=section&id=Overview) This overview section references the "Main Business Activities During the Reporting Period" to emphasize the company's leading position and business layout in the optical lens industry - The main business overview section refers to the content of the 'Main Business Activities During the Reporting Period' chapter[85](index=85&type=chunk) [Year-on-Year Changes in Key Financial Data](index=21&type=section&id=Year-on-Year%20Changes%20in%20Key%20Financial%20Data) Operating revenue increased by 3.68%, while operating costs rose by 7.57%; financial expenses surged by 181.57% due to new special loan interest, and R&D investment significantly increased by 35.45% Year-on-Year Changes in Key Financial Data | Indicator | Current Reporting Period (RMB) | Prior Year Same Period (RMB) | Year-on-Year Change | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 399,171,797.71 | 385,020,343.87 | 3.68% | | | Operating Cost | 168,154,292.23 | 156,322,344.47 | 7.57% | | | Selling Expenses | 67,699,527.68 | 73,582,823.27 | -8.00% | | | Administrative Expenses | 37,358,740.40 | 44,599,105.40 | -16.23% | | | Financial Expenses | 350,557.16 | 124,498.75 | 181.57% | Primarily due to interest from new special loans recognized in financial expenses this period | | Income Tax Expense | 15,162,335.11 | 16,165,062.59 | -6.20% | | | R&D Investment | 19,931,819.45 | 14,715,236.62 | 35.45% | Primarily due to increased R&D investment this period | | Net Cash Flow from Operating Activities | 63,946,345.30 | 71,021,733.53 | -9.96% | | | Net Cash Flow from Investing Activities | -767,733,623.11 | -567,049,129.64 | -35.39% | Primarily due to holding cross-year wealth management funds in the same period, resulting in no concurrent investment cash flow | | Net Cash Flow from Financing Activities | -73,748,211.77 | -67,086,281.38 | -9.93% | | | Net Increase in Cash and Cash Equivalents | -777,648,871.06 | -563,197,355.87 | -38.08% | Primarily due to holding cross-year wealth management funds in the same period, resulting in no concurrent investment cash flow | - The company's profit structure or sources of profit did not undergo significant changes during the reporting period[86](index=86&type=chunk) [Products or Services Accounting for Over 10%](index=21&type=section&id=Products%20or%20Services%20Accounting%20for%20Over%2010%25) Lens products remain the company's core business, generating **RMB 333,402,354.18** in operating revenue this period, a 4.23% increase, with a gross profit margin of 62.40%, slightly down by 1.08% Products or Services Accounting for Over 10% | Product or Service | Operating Revenue (RMB) | Operating Cost (RMB) | Gross Profit Margin | YoY Change in Operating Revenue | YoY Change in Operating Cost | YoY Change in Gross Profit Margin | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Lenses | 333,402,354.18 | 125,369,576.16 | 62.40% | 4.23% | 7.32% | -1.08% | [IV. Analysis of Non-Core Business](index=22&type=section&id=IV.%20Analysis%20of%20Non-Core%20Business) Non-core business contributed to profit primarily through fair value changes (10.62%) and investment income (1.17%), but asset impairment had a negative impact, and these non-core revenues are not sustainable Analysis of Non-Core Business | Item | Amount (RMB) | Share of Total Profit | Reason for Formation | Sustainability | | :--- | :--- | :--- | :--- | :--- | | Investment Income | 1,356,963.98 | 1.17% | Primarily wealth management income | No | | Gains and losses from changes in fair value | 12,321,693.12 | 10.62% | Primarily estimated unrealized wealth management income | No | | Asset Impairment | -3,561,437.05 | -3.07% | Primarily bad debt provisions and inventory depreciation provisions | No | | Non-operating Income | 95,456.30 | 0.08% | Primarily transfer of small outstanding balances no longer payable | No | | Non-operating Expenses | 86,173.06 | 0.07% | Primarily clearing long-aged prepayments | No | [V. Analysis

Group 1 - The company, Mingyue Lens Co., Ltd., has received a notice from its sponsor, Dongfang Securities, regarding the change of the representative responsible for continuous supervision of its initial public offering (IPO) [1] - The original supervising representatives were Zheng Rui and Wen Chang, with the supervision period ending on December 31, 2024, due to unutilized raised funds [1] - Wen Chang has been replaced by Liu Junqing as the new supervising representative to ensure the orderly continuation of supervision duties [1] Group 2 - The board of directors expresses gratitude for Wen Chang's contributions during the IPO and continuous supervision period [1] - Liu Junqing has over ten years of experience in investment banking and has successfully completed multiple IPOs and refinancing projects [3] - Liu Junqing holds a bachelor's and master's degree in economics from Renmin University of China [3]

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 明月镜片股份有限公司（以下简称"公司"）于 2025 年 8 月 26 日收到保荐 机构东方证券股份有限公司（以下简称"东方证券"）《关于更换明月镜片股份 有限公司首次公开发行股票持续督导保荐代表人的情况说明》，东方证券作为公 司首次公开发行股票并在创业板上市的保荐机构，原指定的持续督导保荐代表人 为郑睿先生、温畅先生，持续督导期已于 2024 年 12 月 31 日届满，因公司募集 资金未全部使用完毕，东方证券需继续履行持续督导义务。 证券代码：301101 证券简称：明月镜片 公告编号：2025-022 明月镜片股份有限公司 关于更换持续督导保荐代表人的公告 明月镜片股份有限公司 董 事 会 2025 年 8 月 26 日 附：刘俊清先生简历 刘俊清先生为东方证券产业投行总部董事，注册保荐代表人，中国人民大学 经济学学士、硕士，拥有十余年投行工作经验。刘俊清先生作为签字保荐代表人 成功完成志高机械 IPO、泰鸿万立 IPO、光大同创 IPO、浙江自然 IPO、海晨股份 IPO、博俊科技再融资、天成自控再融资、 ...

Market Performance - The entertainment products sector increased by 0.3% on August 25, with Helen Piano leading the gains [1] - The Shanghai Composite Index closed at 3883.56, up 1.51%, while the Shenzhen Component Index closed at 12441.07, up 2.26% [1] Top Gainers in the Sector - Helen Piano (300329) closed at 13.30, up 8.31% with a trading volume of 248,300 shares and a turnover of 329 million yuan [1] - Zhejiang Zhengte (001238) closed at 51.88, up 5.90% with a trading volume of 12,400 shares and a turnover of 63.59 million yuan [1] - Tianyuan Pet (301335) closed at 35.03, up 5.01% with a trading volume of 118,200 shares and a turnover of 404 million yuan [1] Sector Fund Flow - The entertainment products sector experienced a net outflow of 592 million yuan from institutional investors, while retail investors saw a net inflow of 365 million yuan [2] - Speculative funds had a net inflow of 227 million yuan into the sector [2] Individual Stock Fund Flow - Tongda Chuangzhi (001368) had a net inflow of 19.20 million yuan from institutional investors, but a net outflow of 12.67 million yuan from retail investors [3] - Mingyue Lens (301101) saw a net inflow of 8.90 million yuan from institutional investors, while retail investors had a net outflow of 1.30 million yuan [3] - Helen Piano (300329) experienced a slight net outflow of 0.23 million yuan from institutional investors, with a net inflow of 33.49 million yuan from speculative funds [3]

Group 1 - The core viewpoint of the article highlights the growth in the number of enterprises in the cultural, artistic, sports, and entertainment goods manufacturing industry in China, with a total of 10,958 enterprises reported for the period from January to May 2025, marking an increase of 238 enterprises compared to the same period last year, representing a year-on-year growth of 2.22% [1] - The report indicates that the proportion of these enterprises within the total industrial enterprises stands at 2.11%, reflecting the significance of this sector within the broader industrial landscape [1] - The data referenced in the article is sourced from the National Bureau of Statistics and organized by Zhiyan Consulting, emphasizing the reliability of the information presented [3] Group 2 - Zhiyan Consulting is identified as a leading industry consulting firm in China, specializing in in-depth industry research reports, business plans, feasibility studies, and customized services, showcasing its expertise in providing comprehensive industry solutions [2] - The firm has been dedicated to the industry research field for over a decade, indicating its established presence and experience in the market [2] - Zhiyan Consulting aims to empower investment decisions through its professional insights, quality services, and keen market awareness, positioning itself as a valuable resource for investors [2]

Market Performance - The entertainment products sector increased by 0.85% on August 22, with Qunxing Toys leading the gains [1] - The Shanghai Composite Index closed at 3825.76, up 1.45%, while the Shenzhen Component Index closed at 12166.06, up 2.07% [1] Individual Stock Performance - Qunxing Toys (002575) closed at 9.32, rising by 10.04% with a trading volume of 1.26 million shares and a transaction value of 1.167 billion [1] - Shifeng Culture (002862) closed at 21.24, up 4.84%, with a trading volume of 195,500 shares and a transaction value of 411 million [1] - Helen Piano (300329) closed at 12.28, increasing by 2.50%, with a trading volume of 136,500 shares and a transaction value of 165 million [1] - Other notable stocks include Zhejiang Natural (605080) at 30.73 (+2.19%), Jinling Sports (300651) at 24.86 (+1.47%), and Mingyue Lens (301101) at 49.00 (+1.20%) [1] Fund Flow Analysis - The entertainment products sector saw a net inflow of 86.11 million from institutional investors, while retail investors contributed a net inflow of 80.85 million [2] - The sector experienced a net outflow of 167 million from speculative funds [2] Detailed Fund Flow for Selected Stocks - Qunxing Toys had a net inflow of 192.1 million from institutional investors, but a net outflow of 122 million from speculative funds [3] - Shifeng Culture saw a net inflow of 34.62 million from institutional investors, with a net outflow of 31.82 million from speculative funds [3] - Zhejiang Natural experienced a net inflow of 22.99 million from institutional investors, while speculative funds had a net outflow of 3.35 million [3]

Group 1 - The core viewpoint of the news is that Mingyue Lens has shown a positive stock performance with a year-to-date increase of 16.54% and a recent rise of 6.33% over the last five trading days [1] - As of August 22, the stock price of Mingyue Lens reached 49.39 yuan per share, with a total market capitalization of 9.953 billion yuan [1] - The company has experienced a net inflow of main funds amounting to 1.7069 million yuan, with significant buying and selling activities recorded [1] Group 2 - As of March 31, the number of shareholders for Mingyue Lens increased by 23.10% to 23,100, while the average circulating shares per person decreased by 18.77% to 8,261 shares [2] - For the first quarter of 2025, Mingyue Lens reported a revenue of 197 million yuan, reflecting a year-on-year growth of 2.63% [2] - The company has distributed a total of 272 million yuan in dividends since its A-share listing, with 201 million yuan distributed over the past three years [2]

Group 1 - The stock price of Mingyue Optical reported at 48.42 yuan on August 21, down 1.36% from the previous trading day [1] - The stock experienced a rapid rebound, with a price increase of over 2% within 5 minutes at 9:38 AM, reaching a high of 49.86 yuan [1] - The trading volume for the day was 84,800 hands, with a total transaction amount of 417 million yuan [1] Group 2 - Mingyue Optical operates in the household light industry, focusing on the research, production, and sales of resin lenses [1] - The company's product range includes myopia lenses, presbyopia lenses, and progressive multifocal lenses, widely used in the eyewear manufacturing sector [1] Group 3 - On August 21, the net outflow of main funds was 943,200 yuan, while the cumulative net inflow over the past five trading days was 2,022,080 yuan [1] - The funding situation indicates a short-term inflow trend, but a net outflow on that specific day [1]

明月镜片股份有限公司 简式权益变动报告书 上市公司名称：明月镜片股份有限公司 股票上市地点：深圳证券交易所 股票简称：明月镜片 股票代码：301101 信息披露义务人：上海诺伟其定位投资管理有限公司－宁波梅山保税港区诺伟其 定位创业投资合伙企业（有限合伙） 注册地址：浙江省宁波市北仑区梅山七星路 88 号 1 幢 401 室 A 区 E0320 通讯地址：上海市浦东新区陆家嘴环路 1318 号星展银行大厦 12 楼 股份变动性质：股份减少，持股比例触及 5%。 签署日期：2025 年 8 月 19 日 1 信息披露义务人声明 1、本报告书系信息披露义务人依据《中华人民共和国证券法》《上市公司 收购管理办法》《公开发行证券的公司信息披露内容与格式准则第 15 号——权 益变动报告书》及其他相关法律、法规及规范性文件的有关规定编写。 | 第一节 释义 | | --- | | 第二节 信息披露义务人 . | | 第三节 权益变动目的及持股计划 . | | 第四节 权益变动方式 | | 第五节 前六个月内买卖上市公司股份的情况 . | | 第六节 其他重大事项 . | | 第七节 信息披露义务人声明 . | | 第八 ...